{
    "clinical_study": {
        "@rank": "38482", 
        "arm_group": [
            {
                "arm_group_label": "OFDI-guided PCI & IVUS", 
                "arm_group_type": "Experimental", 
                "description": "Assessment by IVUS at post-PCI\nAssessment by OFDI at a 8-month follow-up"
            }, 
            {
                "arm_group_label": "IVUS-guided PCI & OFDI", 
                "arm_group_type": "Active Comparator", 
                "description": "Assessment by OFDI at post-PCI\nAssessment by OFDI at a 8-month follow-up"
            }
        ], 
        "brief_summary": {
            "textblock": "This study is the sub-study of OPINION Trial. (UMIN000010580) The aim of this study is to\n      evaluate how Optical frequency domain imaging (OFDI) or Intravascular Ultrasound (IVUS)\n      imaging technology influence to the Percutaneous Coronary Intervention (PCI) strategy."
        }, 
        "brief_title": "OPtical Frequency Domain Imaging Versus INtravascular Ultrasound in Percutaneous Coronary InterventiON - OPINION Imaging", 
        "completion_date": {
            "#text": "August 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Coronary Artery Disease", 
        "condition_browse": {
            "mesh_term": [
                "Coronary Artery Disease", 
                "Myocardial Ischemia", 
                "Coronary Disease"
            ]
        }, 
        "detailed_description": {
            "textblock": "Optical frequency domain imaging (OFDI) is a novel, high resolution intravascular imaging\n      modality. Intravascular ultrasound (IVUS) is a widely used conventional imaging modality for\n      achieving optimal stent deployment.\n\n      This study is the sub-study of OPINION Trial. (UMIN000010580) The aim of this study is to\n      evaluate how OFDI or IVUS imaging technology influence to the Percutaneous Coronary\n      Intervention (PCI) strategy.\n\n      We will enroll the first 100 patients who have enrolled in the main-study of OPINION\n      trial.(UMIN000010580). We will assess lesions by the other device in addition to the\n      assigned device in the main study at the time of post-PCI.\n\n      We will then assess lesions by OFDI at a 8-month follo-up."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients participating in the OPINION Trial\n\n          -  Patients who has provided written informed consent\n\n        Exclusion Criteria:\n\n          -  Ineligible patients according to the investigator's judgment\n\n          -  Inability or unwillingness to perform required follow up procedures"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "85 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 27, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01873222", 
            "org_study_id": "TRICVD1311", 
            "secondary_id": "UMIN000010581"
        }, 
        "intervention": [
            {
                "arm_group_label": "OFDI-guided PCI & IVUS", 
                "description": "Assessment by IVUS at post-PCI\nAssessment by OFDI at a 8-month follow-up", 
                "intervention_name": "OFDI-guided PCI & IVUS", 
                "intervention_type": "Device", 
                "other_name": [
                    "OFDI", 
                    "LUNAWAVE", 
                    "Biolimus A9-eluting stent (Nobori stent)"
                ]
            }, 
            {
                "arm_group_label": "IVUS-guided PCI & OFDI", 
                "description": "Assessment by OFDI at post-PCI\nAssessment by OFDI at a 8-month follow-up", 
                "intervention_name": "IVUS-guided PCI & OFDI", 
                "intervention_type": "Device", 
                "other_name": [
                    "VISIWAVE", 
                    "ViewIT", 
                    "Biolimus A9-eluting stent (Nobori stent)"
                ]
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Coronary Artery Disease", 
            "Percutaneous Coronary Intervention", 
            "Optical Frequency Domain Imaging", 
            "Intravascular Ultrasound"
        ], 
        "lastchanged_date": "January 27, 2014", 
        "location": {
            "contact": {
                "email": "OPINION@tri-kobe.org", 
                "last_name": "Takashi Akasaka, MD, PhD", 
                "phone": "+81-73-441-0621"
            }, 
            "facility": {
                "address": {
                    "city": "Wakayama", 
                    "country": "Japan", 
                    "state": "Wakayama Prefecture", 
                    "zip": "641-8510"
                }, 
                "name": "Wakayama Medical University"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Japan"
        }, 
        "number_of_arms": "2", 
        "official_title": "OPtical Frequency Domain Imaging vs. INtravascular Ultrasound in Percutaneous Coronary InterventiON - OPINION Imaging", 
        "overall_contact": {
            "email": "OPINION@tri-kobe.org", 
            "last_name": "Takashi Kubo, MD, PhD", 
            "phone": "+81-73-441-0621"
        }, 
        "overall_official": {
            "affiliation": "Wakayama Medical University", 
            "last_name": "Takashi Akasaka, MD, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Japan: Ethics Committee of Wakayama Medical University", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "August 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "We will assess \"Frequency of malapposed struts\" by OFDI at post-PCI.", 
            "measure": "Frequency of malapposed struts", 
            "safety_issue": "No", 
            "time_frame": "post-PCI"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01873222"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "We will assess \"Minimum stent area\" by IVUS at post-PCI.", 
                "measure": "Minimum stent area", 
                "safety_issue": "No", 
                "time_frame": "post-PCI"
            }, 
            {
                "description": "We will assess \"Dissection\" by OFDI at post-PCI.", 
                "measure": "Dissection", 
                "safety_issue": "No", 
                "time_frame": "post-PCI"
            }, 
            {
                "description": "We will assess \"Frequency of uncovered struts\" by OFDI at 8 months after PCI.", 
                "measure": "Frequency of uncovered struts", 
                "safety_issue": "No", 
                "time_frame": "8 months after PCI"
            }, 
            {
                "description": "We will assess \"Minimum lumen area by OFDI at 8 months after PCI.", 
                "measure": "Minimum lumen area", 
                "safety_issue": "No", 
                "time_frame": "8-month follow-up after PCI"
            }
        ], 
        "source": "Translational Research Informatics Center, Kobe, Hyogo, Japan", 
        "sponsors": {
            "collaborator": {
                "agency": "Wakayama Medical University", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Translational Research Informatics Center, Kobe, Hyogo, Japan", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}